Locations:

Demystifying Mitral Valve Repair (Video)

These 5 techniques can repair 95 percent of degenerative valves

“Mitral valve repair has been turned into this magical operation that only people with magical, Harry Potter-like skills can achieve,” says Cleveland Clinic Cardiothoracic Surgery Chair A. Marc Gillinov, MD. “But it’s neither mysterious nor magical. It’s accessible to all surgeons.”

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

In this five-minute captioned video, Dr. Gillinov makes his case by reviewing and explaining the five surgical techniques that can be used to repair 95 percent of degenerative mitral valves.

Demystifying Mitral Valve Repair

“For posterior leaflet prolapse, [we use] triangular resection or sliding repair. For antileaflet prolapse, the creation of artificial chords. For prolapse at a commissure, [we] close the commissure. The fifth technique is an annuloplasty, which should be incorporated into every single repair.

Let’s break this down. Posterior leaflet prolapse is the most common lesion in degenerative disease, and fortunately it’s the easiest to treat successfully. For segmental posterior leaflet prolapse… [we use] segmental prolapse to a triangular resection and put an annuloplasty. That’s it. A simple, reproducible operation.

If you have extensive posterior leaflet prolapse and a tall leaflet, resection plus a sliding repair will treat the prolapse and prevent postoperative SAM [systolic anterior motion]. That’s all you need for posterior prolapse: Triangular resection, or resection plus sliding repair.

Anterior prolapse is judged, in general, to be more complex, but it’s actually simpler to treat anterior leaflet prolapse. Make artificial chords… How do you measure the artificial chords? That’s always the tricky part… Make new chords, but don’t tie them. Put your ring in, then measure the chords and tie them.

Prolapse at the commissure. This makes a really complex jet easy to repair, simple. Close the commissure. Just sew it shut. You can sew about 20 percent of the valve shut, and as long as you don’t undersize the annuloplasty, you will not have mitral stenosis…

Advertisement

Mitral valve repair is neither mysterious nor magical. It is accessible to all of us.”

Advertisement

Related Articles

scan of a blood vessel with white pointing arrow

Myocardial Bridges: Tailoring Care From Simple to Complex Cases

For severe cases, complete unroofing of the bridge is imperative

Black-and-white scan with red and blue highlights

Revising Carotid Duplex Criteria Helped Identify More Treatable Asymptomatic Stenosis

Lower threshold expanded revascularization candidacy without raising early complication rates

human intestines with inset showing gut microbes

TMAO Emerges as a Biomarker for AAA Risk

Elevated levels of the gut microbial metabolite predict prevalence and adverse outcomes in community-based study

physician pointing to a heart model and speaking to a woman

Cardiovascular Implications of Clonal Hematopoiesis of Indeterminate Potential (CHIP)

They generally depend on the mutated gene, clone size and clinical setting

cardiac echo and cardiac CT images side by side

Indexed CTA Measures Sharpen Risk Prediction in Ascending Aortopathy

Large analysis adds to evidence that absolute diameter alone may miss vulnerable patients

operating room during robotic lung transplant surgery

Successful First Case Launches Cleveland Clinic’s Robotic Lung Transplant Program

Procedure places the center among only a handful worldwide to offer the minimally invasive approach

stylized illustration of cholesterol particle floating in bloodstream

Novel siRNA Produces Deep, Durable Reduction in Lp(a)

Phase 1 trial shows up to 97% decrease through 48 weeks with good tolerability

converging lines on a graph pointing downward

Oxidized Phospholipids Track Closely With Lp(a) Reductions in Clinical Trial

Post hoc ALPACA analysis boosts biological rationale for ongoing outcomes trial of lepodisiran

Ad